EUVIMEDEUVIMED entdecken
Crossref

Exploring rabbit as a nonrodent species for general toxicology studies

Katie Sokolowski, Patricia V Turner, Elise Lewis, Ronald L Wange, Marie C Fortin

Toxicological Sciences · 29.04.2024 · 199 (1) · 29-39

DOI: 10.1093/toxsci/kfae022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 19.02.2024. Verfasst von Katie Sokolowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Safety Assessment, Development Sciences, Denali Therapeutics Inc, South San Francisco, California 94080, USA. Hauptthemen laut MEDLINE: Toxicity Tests. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To avoid adverse events in humans, toxicity studies in nonclinical species have been the foundation of safety evaluation in the pharmaceutical industry. However, it is recognized that working with animals in research is a privilege, and conscientious use should always respect the 3Rs: replacement, reduction, and refinement. In the wake of the shortages in routine nonrodent species and considering that nonanimal methods are not yet sufficiently mature, the value of the rabbit as a nonrodent species is worth exploring. Historically used in vaccine, cosmetic, and medical device testing, the rabbit is seldom used today as a second species in pharmaceutical development, except for embryo-fetal development studies, ophthalmic therapeutics, some medical devices and implants, and vaccines. Although several factors affect the decision of species selection, including pharmacological relevance, pharmacokinetics, and ADME considerations, there are no perfect animal models. In this forum article, we bring together experts from veterinary medicine, industry, contract research organizations, and government to explore the pros and cons, residual concerns, and data gaps regarding the use of the rabbit for general toxicity testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toxicity TestsRabbitsAnimalsSpecies SpecificityModels, AnimalAnimal Testing AlternativesHumansToxicology

Stichwörter der Autor:innen

NHP shortagegeneral toxicology testingnonrodent speciesrabbitshortage

Autor:innen und Institutionen

  • Safety Assessment, Development Sciences, Denali Therapeutics Inc, South San Francisco, California 94080, USA.
  • Global Animal Welfare & Training, Charles River Laboratories, Wilmington, Massachusetts 01887, USA.
  • Department of Pathobiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
  • Safety Assessment, Charles River Laboratories, Horsham, Pennsylvania 19044, USA.
  • Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, USA.
  • Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA.

Zitieren

APA

Sokolowski, K., Turner, P. V., Lewis, E., Wange, R. L., & Fortin, M. C. (2024). Exploring rabbit as a nonrodent species for general toxicology studies. Toxicological Sciences, 199(1), 29-39. https://doi.org/10.1093/toxsci/kfae022

Vancouver

Sokolowski K, Turner PV, Lewis E, Wange RL, Fortin MC. Exploring rabbit as a nonrodent species for general toxicology studies. Toxicological Sciences. 2024;199(1):29-39. doi:10.1093/toxsci/kfae022

BibTeX
@article{Sokolowski2024,
  author = {Sokolowski, Katie and Turner, Patricia V and Lewis, Elise and Wange, Ronald L and Fortin, Marie C},
  title = {Exploring rabbit as a nonrodent species for general toxicology studies},
  journal = {Toxicological Sciences},
  year = {2024},
  volume = {199},
  number = {1},
  pages = {29--39},
  doi = {10.1093/toxsci/kfae022}
}
Kostenlos starten →